Ypsomed
Emmett Farrell is a highly experienced professional in regulatory affairs and quality assurance, currently serving as Senior Manager Regulatory Affairs at Ypsomed AG since July 2022. Previously, Emmett held positions including Head of Quality Assurance and Regulatory Affairs at Experiment X GmbH, and Quality Assurance/Regulatory Affairs Manager at Leila. Emmett's background includes significant roles in quality assurance, notably at CAScination AG, where responsibilities included ensuring compliance with ISO 13485:2016, MDD, and 21 CFR Title 820, managing supplier quality, and implementing MDR. Additional experience includes Quality Assurance Engineer at Novocure and Staff Engineer Supplier Quality at Stryker, among others. Emmett holds a Master’s Degree in Operations and Quality Management from the University of Galway and a Bachelor’s Degree in Production Management from the University of Limerick.
This person is not in any teams
This person is not in any offices
Ypsomed
4 followers
Ypsomed Holding AG is a Switzerland-based holding company engaged in the manufacture of injection pens for pharmaceutical and biotech companies. The Company develops and manufactures injection systems for custom-made self-administration, and markets pen needles for the treatment of diabetes, growth disorders or infertility, as well as therapeutic areas. The Company operates two business segments: Injection Systems and Diabetes Care. In the Injection Systems segment, the Company's YDS Ypsomed Delivery Systems offer a range of ready-to-use injection systems for pharmaceutical and biotech companies to administer of drugs or to develop and manufacture them in line with customer requirements. The Diabetes Care segment markets products such as pen needles or insulin pump to diabetics, doctors and health insurance providers. The Company operates its production sites in Burgdorf, Solothurn, Grenchen and Tabor, and sales and distribution network across Europe.